483 Response Fougera Pharmaceuticals Oct 2001

Rochelle Kimmel FDA, Felix Maldonado FDA, Althea Williams FDA$119.00 - Available Now

FDA investigators audited the Fougera Pharmaceuticals - Melville, NY, United States facility and issued inspectional observation (via FDA 483) on 18 Oct 2001.

Product details

  • Category:
  • Inspection end: 18 Oct 2001
  • Location: Melville, United States
  • FEI: 2432435
Add To Cart